Back to Stakeholders
Research, Drug Development & ManufacturingLead program: Pre-clinical
PharmaDrugCSE: PHRX | OTC Pink: LMLLF
1 Drug Candidate
PharmaDrug is a Canadian specialty pharmaceutical company focused on the research and development of controlled substances and natural medicines. Through its Sairiyo Therapeutics subsidiary, the company is developing a DMT candidate with FDA Orphan Drug Designation for prevention of ischemia-reperfusion injury in organ transplants, and is also studying DMT for ophthalmic indications. PharmaDrug also distributes medical cannabis in the EU via PharmaDrug Production GmbH.
Drug Pipeline
1DMT (Sairiyo Therapeutics)
DMTPre-clinical
DMT candidate with FDA Orphan Drug Designation for prevention of ischemia-reperfusion injury resulting from organ transplants; also under investigation for ophthalmic disease including glaucoma.
Quick Facts
- Type
- Public Biotech
- Ticker
- CSE: PHRX | OTC Pink: LMLLF
- Lead Stage
- Pre-clinical
- Website
- Visit